Guest guest Posted April 22, 2006 Report Share Posted April 22, 2006 E-NEWS FROM THE NATIONAL VACCINE INFORMATION CENTER Vienna, Virginia http://www.nvic.org * * * * * * * * * * * * * * * * * * * * * * * UNITED WAY/COMBINED FEDERAL CAMPAIGN #8122 * * * * * * * * * * * * * * * * * * * * * * * " Protecting the health and informed consent rights of children since 1982. " ============================================================================ ============== " In Iowa, for example, 64 percent of those who came down with the mumps had two doses of the vaccine. Another 10 percent had one dose. In almost all the other cases, the patient's vaccination records were unknown. Only 3 percent of the patients are confirmed to not have had the vaccine. " Most of the kids who got mumps in Iowa had received two doses of MMR vaccine. But the CDC is sticking by its story which is: " The CDC reports the [mumps] vaccine is 90 percent to 95 percent effective and that immunity should last more than 25 years, probably a lifetime. " The CDC should admit that, when they work, vaccines only confer temporary immunity. Natural recovery from mumps disease in childhood, which has a very low incidence of serious complications, confers a qualitatively superior immunity that can be permanent. http://www.mysanantonio.com/news/metro/stories/MYSA041606.5A.mumps.vaccine.2 670429.html Experts now have hundreds of reasons to question mumps vaccine Web Posted: 04/16/2006 12:00 AM CDT a Herrndobler Hearst Newspapers WASHINGTON — A major mumps outbreak in eight Midwestern states has raised questions about the effectiveness of the mumps vaccine routinely given to children. More than 600 cases of mumps have been reported in Iowa, compared with three cases last year. Wisconsin, Indiana, Michigan, Illinois, Nebraska, Kansas and Missouri have reported a total of more than 100 cases to the federal Centers for Disease Control and Prevention. The outbreak adds up to the largest mumps outbreak in 20 years. The CDC has sent teams of health experts to Iowa to study the outbreaks and the vaccine's effectiveness. " We don't know as of yet why some of those who have received two doses (of vaccine) are contracting mumps, " said Lola , CDC spokeswoman, reflecting the puzzlement of other health experts trying to explain why many mumps victims had received the recommended two doses of vaccine. In Iowa, for example, 64 percent of those who came down with the mumps had two doses of the vaccine. Another 10 percent had one dose. In almost all the other cases, the patient's vaccination records were unknown. Only 3 percent of the patients are confirmed to not have had the vaccine. Stanley Perlman, a professor of pediatrics and infectious diseases at the University of Iowa, said the outbreak might prove that " the vaccine is just OK — and not wonderful. " Ken Haller, an assistant professor of pediatrics at St. Louis University School of Medicine, said the outbreak might indicate immunity to mumps weakens years after the vaccination. , at the CDC, said the vaccine is working. " If the vaccine was not working, we would see a higher incident of mumps in Iowa and the surrounding states, " she said. " The advice we are giving is that the MMR vaccine is the most effective means of protection. " The CDC reports the vaccine is 90 percent to 95 percent effective and that immunity should last more than 25 years, probably a lifetime. ============================================= News@... is a free service of the National Vaccine Information Center and is supported through membership donations. Learn more about vaccines, diseases and how to protect your informed consent rights http://www.nvic.org Become a member and support NVIC's work https://www.nvic.org/making%20cash%20donations.htm To sign up for a free e-mail subscription http://www.nvic.org/emaillist.htm Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.